ArthroCare(R) Receives FDA Clearance for SpeedLock(R) Knotless Fixation Device

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedLock(R)┬áKnotless Fixation Device (SpeedLock). SpeedLock, a push-in implant made of PEEK (polyether-etherketone) polymer, provides surgeons with independent bone lock, suture tensioning and suture lock and is indicated for soft tissue fixation to bone, primarily in labral repair procedures. SpeedLock is expected to complement ArthroCare’s broad line of suture anchors and ArthroCare’s suture passing technology, including the SpeedStitch(R)suturing device.


ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation(R)technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS(R)┬áline of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.

Source: ArthroCare